REFERENCES
- Heyman A, Pfeiffer J B, Willett R, et al. Peripheral neuropathy caused by arsenical intoxication. N Engl J Med 1956; 254: 401–409
- Hoover T D, Aposhian H V. BAL increases the arsenic-74 content of rabbit brain. Toxicol App Pharmacol 1983; 70: 160–162
- Schafer B, Kreppel H, Reichl F X, et al. Effect of oral treatment with BAL, DMPS or DMSA. Arsenic in organs of mice injected with arsenic trioxide. Arch Toxicol 1991; 14: 228–230
- Aposhian V, Maiorino R M, Rivera N, et al. Human studies with the chelating agents, DMPS and DMSA. J Toxiocol Clin Toxicol 1992; 30: 505–528
- Petrunkin V E. Synthese und eigenschaften der dimerkaptoderivate von alkansulfonsauren. Ukrain Khim Zhur 1956; 22: 603–611
- Aposhian V H. DMSA and DMPS–Water soluble antidotes for heavy metal poisoning. Ann Rev Pharmacol Toxicol 1983; 23: 193–215
- Aposhian H V, Arroyo A, Cebrian M E, et al. DMPS-arsenic challenge test. I: Increased urinary excretion of monomethylarsonic acid in humans given dimercaptopropane sulfonate J Pharmacol Exper Therap 1997; 282: 192–200
- Goebel H H, Schmidt P F, Bohl J, et al. Polyneuropathy due to acute arsenic intoxication: Biopsy studies. J Aleuropath Exper Neurol 1990; 49: 137–149
- Moore D F, O'Callaghan, Berlyne G, et al. Acute arsenic poisoning: Absence of polyneuropathy after treatment with 2,3-dimercatopropanesulfphonate (DMPS). J Neurol Neurosurg Psychiatr 1994; 57: 1133–1135